EUVIMEDEUVIMED entdecken
Open Access

Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1 H )-one derivatives as antioxidant and α -amylase inhibitors

Neelam Yadav, Ravi Kumar iD, Sarita Sangwan, Vidhi Dhanda, Anil Duhan, Jayant Sindhu

Future Medicinal Chemistry · 2024

DOI: 10.1080/17568919.2024.2432289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Neelam Yadav und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India. Hauptthemen laut MEDLINE: alpha-Amylases, Antioxidants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Council of Scientific and Industrial Research, India & University Grant Commission, New Delhi, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: Oxidative stress, caused by postprandial activities, is a major global health issue causing chronic diseases like diabetes mellitus, cancer, and asthma. Therefore, it was envisaged to design and synthesize a series of substituted 4-hydroxypyridine-2(1 h)-ones in order to develop new molecules that can reduce oxidative stress and modulate α-amylase activity also. MATERIALS & METHODS: An environmentally benign, solvent and catalyst free, natural product inspired synthesis of 4-hydroxypyridin-2(1 h)-one derivatives has been developed. The synthetic analogues were evaluated in vitro α-amylase activity and antioxidant potential. RESULTS: Among all the synthesized compounds, 4a, 4c, and 4d displayed many folds higher antioxidants activity than the standard, BHT. The in vitro α-amylase inhibition was found to be moderate with IC50 values ranging from 5.48 to 9.31 mm as compared to the standard acarbose (IC50 = 0.65 mm). The most active compound against α-amylase 4c was further investigated for its binding affinity within the active site of the enzyme and the kinetics studies revealed probable uncompetitive mode of inhibition. CONCLUSION: Compound 4a was found to be promising antioxidant and 4c as a good α-amylase inhibitor. These compounds could pave the way for development of new α-amylase inhibitors with antioxidant capabilities thereby effectively mitigating diabetes mellitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-AmylasesAntioxidantsStructure-Activity RelationshipHumansMolecular Docking SimulationMolecular StructurePyridonesEnzyme Inhibitors

Stichwörter der Autor:innen

2-pyridonediabetesmolecular dockingoxidative stresssolvent free synthesisα-amylase inhibitor

Substanzen

alpha-AmylasesAntioxidantsPyridonesEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.
  • MAP Section, Department of Genetics and Plant Breeding, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.
  • Center for Bio-Nanotechnology, Chaudhary Charan Singh Haryana Agricultural University Hisar, Hisar, Haryana, India.

ORCID-Profile: Ravi Kumar

Förderung

  • Council of Scientific and Industrial Research, India & University Grant Commission, New Delhi, India

Zitieren

APA

Yadav, N., Kumar, R., Sangwan, S., Dhanda, V., Duhan, A., & Sindhu, J. (2024). Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1 H )-one derivatives as antioxidant and α -amylase inhibitors. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2432289

Vancouver

Yadav N, Kumar R, Sangwan S, Dhanda V, Duhan A, Sindhu J. Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1 H )-one derivatives as antioxidant and α -amylase inhibitors. Future Medicinal Chemistry. 2024. doi:10.1080/17568919.2024.2432289

BibTeX
@article{Yadav2024,
  author = {Yadav, Neelam and Kumar, Ravi and Sangwan, Sarita and Dhanda, Vidhi and Duhan, Anil and Sindhu, Jayant},
  title = {Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1 H )-one derivatives as antioxidant and α -amylase inhibitors},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.1080/17568919.2024.2432289}
}
Kostenlos starten →